Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection L Townsend, AH Dyer, K Jones, J Dunne, A Mooney, F Gaffney, ... PloS one 15 (11), e0240784, 2020 | 938 | 2020 |
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 456 | 2021 |
The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity AH Dyer, C Vahdatpour, A Sanfeliu, D Tropea Neuroscience 325, 89-99, 2016 | 336 | 2016 |
Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity L Townsend, J Dowds, K O’Brien, G Sheill, AH Dyer, B O’Kelly, JP Hynes, ... Annals of the American Thoracic Society 18 (6), 997-1003, 2021 | 327 | 2021 |
Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response L Townsend, H Fogarty, A Dyer, I Martin‐Loeches, C Bannan, ... Journal of Thrombosis and Haemostasis 19 (4), 1064-1070, 2021 | 209 | 2021 |
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 133 | 2022 |
Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study GMR Collaborative Age and Ageing, 2021 | 121 | 2021 |
Dementia in the acute hospital: the prevalence and clinical outcomes of acutely unwell patients with dementia R Briggs, A Dyer, S Nabeel, R Collins, J Doherty, T Coughlan, D O’neill, ... QJM: An International Journal of Medicine 110 (1), 33-37, 2017 | 118 | 2017 |
Insulin-like growth factor 1 and related compounds in the treatment of childhood-onset neurodevelopmental disorders C Vahdatpour, AH Dyer, D Tropea Frontiers in neuroscience 10, 218672, 2016 | 70 | 2016 |
Illness severity, social and cognitive ability, and EEG analysis of ten patients with Rett syndrome treated with Mecasermin (Recombinant Human IGF‐1) G Pini, L Congiu, A Benincasa, P DiMarco, S Bigoni, AH Dyer, N Mortimer, ... Autism Research and Treatment 2016 (1), 5073078, 2016 | 65 | 2016 |
Safety and efficacy of non‐steroidal anti‐inflammatory drugs to reduce ileus after colorectal surgery EuroSurg Collaborative, SJ Chapman, D Clerc, R Blanco‐Colino, A Otto, ... British Journal of Surgery 107 (2), e161-e169, 2020 | 56 | 2020 |
Asymptomatic carriage rates and case fatality of SARS-CoV-2 infection in residents and staff in Irish nursing homes SP Kennelly, AH Dyer, R Martin, SM Kennelly, A Martin, D O'Neill, F A Age and Ageing, 2020 | 53 | 2020 |
Longitudinal analysis of COVID-19 patients shows age-associated T cell changes independent of ongoing ill-health L Townsend, AH Dyer, A Naughton, R Kiersey, D Holden, M Gardiner, ... Frontiers in immunology 12, 676932, 2021 | 48 | 2021 |
Gait speed, cognition and falls in people living with mild-to-moderate Alzheimer disease: data from NILVAD AH Dyer, B Lawlor, SP Kennelly BMC geriatrics 20, 1-10, 2020 | 35 | 2020 |
Investigating the relationship between vitamin D and persistent symptoms following SARS-CoV-2 infection L Townsend, AH Dyer, P McCluskey, K O’Brien, J Dowds, E Laird, ... Nutrients 13 (7), 2430, 2021 | 32 | 2021 |
Social networks in mild-to-moderate Alzheimer disease: longitudinal relationships with dementia severity, cognitive function, and adverse events AH Dyer, C Murphy, B Lawlor, SP Kennelly, N Study Group Aging & Mental Health 25 (10), 1923-1929, 2021 | 31 | 2021 |
Non-pharmacological interventions for cognition in patients with type 2 diabetes mellitus: a systematic review AH Dyer, R Briggs, D Mockler, J Gibney, SP Kennelly QJM: An International Journal of Medicine 113 (3), 155-161, 2020 | 31 | 2020 |
Cognitive outcomes of long-term benzodiazepine and related drug (BDZR) use in people living with mild to moderate Alzheimer's disease: results from NILVAD AH Dyer, C Murphy, B Lawlor, SP Kennelly, R Segurado, S Kennelly, ... Journal of the American Medical Directors Association 21 (2), 194-200, 2020 | 31 | 2020 |
Previous SARS-CoV-2 infection, age, and frailty are associated with 6-month vaccine-induced anti-spike antibody titer in nursing home residents AH Dyer, C Noonan, M McElheron, I Batten, C Reddy, E Connolly, ... Journal of the American Medical Directors Association 23 (3), 434-439, 2022 | 29 | 2022 |
Managing the impact of COVID-19 in nursing homes and long-term care facilities: an update AH Dyer, A Fallon, C Noonan, H Dolphin, C O’Farrelly, NM Bourke, ... Journal of the American Medical Directors Association 23 (9), 1590-1602, 2022 | 26 | 2022 |